Survivin-induced abnormal ploidy contributes to cystic kidney and aneurysm formation

Wissam A Aboualaiwi1, Brian S Muntean, Shobha Ratnam

  • 1Department of Pharmacology (W.A.A., S.M.N.), Department of Medicinal and Biological Chemistry (B.S.M., S.M.N.), Department of Medicine (S.R., S.M.N.), Center for Hypertension and Personalized Medicine (B.J., S.M.N.), Department of Biochemistry and Cancer Biology (L.L.), and Department of Pathology (R.L.B.), University of Toledo, Toledo, OH; Department of Emergency and Intensive Care, ProMedica Sponsored Research, Toledo, OH (I.R.); Departments of Medicine (B.S.H.) and Medical and Molecular Genetics (R.L.B.), Indiana University School of Medicine, Indianapolis; UCL Institute of Ophthalmology, University College London, London, UK (M.F.); Ontario Cancer Institute, University Health Network, Toronto, ON, Canada (T.W.M.); and Department of Medicine, Brigham and Women's Hospital, Boston, MA (J.Z.).

Circulation
|November 16, 2013
PubMed
Abstract

Insights

Polycystic kidney disease involves cystic kidneys and vascular aneurysms linked to low survivin expression. Restoring survivin rescues kidney cysts, revealing a shared pathway for renal and vascular defects.

Area of Science:

  • Cell Biology
  • Genetics
  • Pathology

Background:

  • Polycystic kidney disease (PKD) is a ciliopathy causing cystic kidneys and vascular aneurysms.
  • Survivin is known for cancer but its role in PKD pathology was unstudied.
  • This study investigates survivin's role in PKD-related kidney and vascular defects.

Purpose of the Study:

  • To examine how cilia function and structure influence kidney cysts and aneurysms via survivin downregulation.
  • To elucidate the molecular mechanisms linking cilia, survivin, and PKD phenotypes.

Main Methods:

  • Analysis of cysts and aneurysms from PKD patients and models (mouse, zebrafish).
  • In vivo studies using conditional knockout mouse and zebrafish models for survivin.
  • Investigating flow-induced cilia activation pathways (PKC, Akt, NF-κB).

Main Results:

  • PKD cysts and aneurysms show chromosome instability and reduced survivin.
  • Survivin deficiency causes kidney cysts and abnormal cell division in kidneys and vasculature.
  • Re-expressing survivin rescues PKD phenotypes, indicating its critical role.

Conclusions:

  • A unifying mechanism for PKD renal and vascular phenotypes involving cilia, survivin, and cell division is proposed.
  • Cilia dysfunction, not hypertension, drives aneurysm formation in PKD.
  • Shared pathways including cilia, survivin, cytokinesis, and cell ploidy link cyst and aneurysm formation.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
3.8K
Healing II: Complications01:24

Healing II: Complications

Complications during healing arise when tissue repair is altered by local or systemic factors. These changes involve abnormal collagen deposition, altered biomechanics, and reduced vascular supply, impairing restoration of normal structure and function.Loss of FunctionScar tissue differs significantly from the original tissue it replaces. In the skin, fibrosis lacks adnexal structures such as hair follicles, sebaceous glands, and sweat glands. Their absence reduces tactile sensitivity, impairs...
37
Ascites01:19

Ascites

DefinitionAscites is the buildup of fluid inside the peritoneal cavity. It occurs when fluid moves out of the vascular system faster than the peritoneal lymphatics can remove it. This fluid shift is most commonly seen in liver cirrhosis but can also appear in several other systemic disorders.EtiologyCirrhosis remains the leading cause of ascites. Other conditions that can contribute include:Heart failureConstrictive pericarditisAbdominal cancersNephrotic syndromeSevere protein–calorie...
47